TCL Archive Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34% June 28, 2013
TCL Archive High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial November 28, 2008
TCL Archive Clinton Proposes $1.15 Billion Increase For NIH; Support For Cancer Research January 30, 1998
TCL Archive Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions November 4, 1983